CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7,55
arrow_upward
+1,75%(+0,13) 1D
11 Nov., 16:10:09 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7,40
High
A$7,76
Low
A$7,40
Mkt. cap
381,18 m
Avg. vol.
154,28 k
Volume
204,17 k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,30
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
Open
A$7,40
High
A$7,76
Low
A$7,40
Mkt. cap
381,18 m
Avg. vol.
154,28 k
Volume
204,17 k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,30
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
News stories
From web sources and news partners
markets.businessinsider.com
·
43 minute gelede
Rantizo (Nasdaq: RNTZ) Advances U.S. Production of Heavy-Lift Autonomous Drones After $258.8 Million Acquisition, Targets California’s $61.2 Billion Agricultural Market
PR Newswire Canada
·
20 minute gelede
NYSE Honors Those Who Have Served on Veterans Day: NYSE Content Update
Reuters
·
3 uur gelede
Mapping the Market: S&P 500 at risk of further losses
Bloomberg.com
·
1 uur gelede
AI Malaise, Midterms Cloud 2027 Profits After Blowout Quarter
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
Industry-
Websiteclinuvel.com